COL17A1 and allergic disease: showed a higher prevalence of preclinical anti-BP180 autoantibodies (23.8%) in elderly patients with pruritic disorders than that in elderly patients with allergic diseases (4.2%) by BP180 N-terminus and C-terminus ELISAs (49).